Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 18445 | 551 | 30.9 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
| 154 | 3 | PSYCHIATRY//ALEXITHYMIA//PSYCHIAT | 62481 |
| 207 | 2 | PSYCHIATRY//ANTIDEPRESSANTS//DEPRESSION | 21074 |
| 18445 | 1 | SEROTONIN SYNDROME//SEROTONIN TOXICITY//5 HT ENHANCING DRUG | 551 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | SEROTONIN SYNDROME | authKW | 5062198 | 28% | 59% | 155 |
| 2 | SEROTONIN TOXICITY | authKW | 666836 | 3% | 63% | 19 |
| 3 | 5 HT ENHANCING DRUG | authKW | 110834 | 0% | 100% | 2 |
| 4 | SEROTONIN TOXICITY SYNDROME | authKW | 110834 | 0% | 100% | 2 |
| 5 | COMPLICATIONS SEROTONIN SYNDROME | authKW | 73888 | 0% | 67% | 2 |
| 6 | POPULAT HLTH USE MED UNIT | address | 73888 | 0% | 67% | 2 |
| 7 | MONOAMINE OXIDASE INHIBITORS | authKW | 69587 | 4% | 6% | 21 |
| 8 | 5 HT 5 HYDROXYTYPTAMINE | authKW | 55417 | 0% | 100% | 1 |
| 9 | 5 HT1A AND 5 HT2 RECEPTOR SUBTYPES | authKW | 55417 | 0% | 100% | 1 |
| 10 | ACUTE PSYCHIAT ASSESSMENT UNIT | address | 55417 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Anesthesiology | 2595 | 13% | 0% | 73 |
| 2 | Psychiatry | 1869 | 22% | 0% | 119 |
| 3 | Pharmacology & Pharmacy | 1141 | 28% | 0% | 154 |
| 4 | Emergency Medicine | 740 | 5% | 0% | 28 |
| 5 | Clinical Neurology | 430 | 13% | 0% | 74 |
| 6 | Medicine, Legal | 247 | 2% | 0% | 13 |
| 7 | Medicine, General & Internal | 202 | 10% | 0% | 57 |
| 8 | Critical Care Medicine | 175 | 4% | 0% | 21 |
| 9 | Neurosciences | 132 | 11% | 0% | 63 |
| 10 | Toxicology | 79 | 4% | 0% | 24 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | POPULAT HLTH USE MED UNIT | 73888 | 0% | 67% | 2 |
| 2 | ACUTE PSYCHIAT ASSESSMENT UNIT | 55417 | 0% | 100% | 1 |
| 3 | ANAESTHET CHRON PAIN | 55417 | 0% | 100% | 1 |
| 4 | AUBURN MENTAL HLTH UNIT | 55417 | 0% | 100% | 1 |
| 5 | BANNER GOOD SAMARITAN MED TOXICOL PHARM | 55417 | 0% | 100% | 1 |
| 6 | BRITISH COLUMBIA REG ADVERSE DRUG REACT REPORTIN | 55417 | 0% | 100% | 1 |
| 7 | CENT NEW YORK MASTER PUBL HLTH PROGRAM | 55417 | 0% | 100% | 1 |
| 8 | FAK PSIKIYATRI ABD | 55417 | 0% | 100% | 1 |
| 9 | GENESIS REHABIL SERV | 55417 | 0% | 100% | 1 |
| 10 | INTENS CARE 7D16 | 55417 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PRESCRIRE INTERNATIONAL | 11082 | 0% | 20% | 1 |
| 2 | COMPREHENSIVE THERAPY | 6925 | 0% | 13% | 1 |
| 3 | ANNALS OF PHARMACOTHERAPY | 6418 | 5% | 0% | 25 |
| 4 | FOCUS ON DEPRESSION AND ANXIETY | 3956 | 0% | 7% | 1 |
| 5 | CLINICAL NEUROPHARMACOLOGY | 2300 | 2% | 0% | 10 |
| 6 | ANASTHESIOLOGIE UND INTENSIVMEDIZIN | 2051 | 0% | 4% | 1 |
| 7 | JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 1298 | 1% | 0% | 8 |
| 8 | JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 1254 | 1% | 0% | 7 |
| 9 | INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY | 1076 | 1% | 0% | 6 |
| 10 | JOURNAL OF CLINICAL ANESTHESIA | 1048 | 1% | 0% | 7 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | IQBAL, MM , BASIL, MJ , KAPLAN, J , IQBAL, T , (2012) OVERVIEW OF SEROTONIN SYNDROME.ANNALS OF CLINICAL PSYCHIATRY. VOL. 24. ISSUE 4. P. 310 -318 | 33 | 73% | 23 |
| 2 | KECK, PE , ARNOLD, LM , (2000) THE SEROTONIN SYNDROME.PSYCHIATRIC ANNALS. VOL. 30. ISSUE 5. P. 333 -343 | 34 | 85% | 23 |
| 3 | SUN-EDELSTEIN, C , TEPPER, SJ , SHAPIRO, RE , (2008) DRUG-INDUCED SEROTONIN SYNDROME: A REVIEW.EXPERT OPINION ON DRUG SAFETY. VOL. 7. ISSUE 5. P. 587-596 | 30 | 67% | 42 |
| 4 | WOYTOWISH, MR , MAYNOR, LM , (2013) CLINICAL RELEVANCE OF LINEZOLID-ASSOCIATED SEROTONIN TOXICITY.ANNALS OF PHARMACOTHERAPY. VOL. 47. ISSUE 3. P. 388-397 | 20 | 91% | 7 |
| 5 | HABERZETTL, R , BERT, B , FINK, H , FOX, MA , (2013) ANIMAL MODELS OF THE SEROTONIN SYNDROME: A SYSTEMATIC REVIEW.BEHAVIOURAL BRAIN RESEARCH. VOL. 256. ISSUE . P. 328-345 | 56 | 30% | 19 |
| 6 | YALUG, I , OZDEMIR, S , AKER, T , (2008) A BRIEF REVIEW OF SEROTONIN SYNDROME.NEUROLOGY PSYCHIATRY AND BRAIN RESEARCH. VOL. 15. ISSUE 1. P. 1-6 | 29 | 73% | 0 |
| 7 | GILLMAN, PK , (1998) SEROTONIN SYNDROME: HISTORY AND RISK.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 12. ISSUE 5. P. 482 -491 | 41 | 61% | 69 |
| 8 | ROZEC, B , CINOTTI, R , BLANLOEIL, Y , (2011) PERIOPERATIVE ADVERSE EVENTS RELATED TO ANTIDEPRESSIVE AGENTS USE.ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION. VOL. 30. ISSUE 11. P. 828-840 | 45 | 42% | 0 |
| 9 | ALUSIK, S , KALATOVA, D , PALUCH, Z , (2014) SEROTONIN SYNDROME.NEUROENDOCRINOLOGY LETTERS. VOL. 35. ISSUE 4. P. 265 -273 | 29 | 58% | 4 |
| 10 | GILLMAN, PK , (1999) THE SEROTONIN SYNDROME AND ITS TREATMENT.JOURNAL OF PSYCHOPHARMACOLOGY. VOL. 13. ISSUE 1. P. 100 -109 | 30 | 70% | 126 |
Classes with closest relation at Level 1 |